PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32203934-0	2020	Regulation of docetaxel chemosensitivity by NR2F6 in breast cancer.	Docetaxel	14-23	nuclear receptor subfamily 2 group F member 6	Homo sapiens	44-49	
32203934-4	2020	Herein, both data mining and profiling analysis using clinical BCa biopsies showed that expression levels of the nuclear receptor subfamily 2, group F, member 6 (NR2F6), a recently characterized central transcription factor for cancer immune surveillance, were significantly downregulated in DTX-resistant BCa.	Docetaxel	292-295	nuclear receptor subfamily 2 group F member 6	Homo sapiens	113-160	
32203934-4	2020	Herein, both data mining and profiling analysis using clinical BCa biopsies showed that expression levels of the nuclear receptor subfamily 2, group F, member 6 (NR2F6), a recently characterized central transcription factor for cancer immune surveillance, were significantly downregulated in DTX-resistant BCa.	Docetaxel	292-295	nuclear receptor subfamily 2 group F member 6	Homo sapiens	162-167	
32203934-6	2020	In both genetically engineered cell models and patient-derived xenograft models, we provided evidence that BCa cells with insufficient NR2F6 expression were less responsive to DTX treatment.	Docetaxel	176-179	nuclear receptor subfamily 2 group F member 6	Homo sapiens	135-140	
32203934-8	2020	Stable PDGFRB inhibition ameliorated NR2F6 deficiency-impaired response to DTX in BCa cells, indicating that NR2F6"s effect on DTX response is mediated, at least in part, through transcriptional repression of PDGFRB.	Docetaxel	75-78	nuclear receptor subfamily 2 group F member 6	Homo sapiens	37-42	
32203934-8	2020	Stable PDGFRB inhibition ameliorated NR2F6 deficiency-impaired response to DTX in BCa cells, indicating that NR2F6"s effect on DTX response is mediated, at least in part, through transcriptional repression of PDGFRB.	Docetaxel	75-78	nuclear receptor subfamily 2 group F member 6	Homo sapiens	109-114	
32203934-8	2020	Stable PDGFRB inhibition ameliorated NR2F6 deficiency-impaired response to DTX in BCa cells, indicating that NR2F6"s effect on DTX response is mediated, at least in part, through transcriptional repression of PDGFRB.	Docetaxel	127-130	nuclear receptor subfamily 2 group F member 6	Homo sapiens	37-42	
32203934-8	2020	Stable PDGFRB inhibition ameliorated NR2F6 deficiency-impaired response to DTX in BCa cells, indicating that NR2F6"s effect on DTX response is mediated, at least in part, through transcriptional repression of PDGFRB.	Docetaxel	127-130	nuclear receptor subfamily 2 group F member 6	Homo sapiens	109-114